tegafur has been researched along with Stevens-Johnson Syndrome in 3 studies
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
Excerpt | Relevance | Reference |
---|---|---|
"TS-1 has been used for the treatment of gastric cancer, both in the adjuvant and metastatic setting, and is increasingly being used in other malignancies such as colon, pancreatic and non-small cell lung cancer." | 1.37 | Toxic epidermal necrolysis associated with TS-1 in a patient with gastric cancer. ( Aw, CW; Lee, SC; Lim, R; Lim, TC; Tan, CS; Yeo, SW, 2011) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Komatsu-Fujii, T | 1 |
Ogawa, M | 1 |
Nonoyama, S | 1 |
Fukumoto, T | 1 |
Tanabe, H | 1 |
Tan, CS | 1 |
Lim, R | 1 |
Lim, TC | 1 |
Aw, CW | 1 |
Yeo, SW | 1 |
Lee, SC | 1 |
Yamazaki, Y | 1 |
Yamada, A | 1 |
Sugaya, S | 1 |
Osawa, A | 1 |
3 other studies available for tegafur and Stevens-Johnson Syndrome
Article | Year |
---|---|
Recurrence of nivolumab-induced Stevens-Johnson syndrome due to tegafur/gimeracil/oteracil (TS-1®) after nivolumab discontinuation.
Topics: Aged; Antineoplastic Agents, Immunological; Drug Combinations; Female; Humans; Nivolumab; Oxonic Aci | 2021 |
Toxic epidermal necrolysis associated with TS-1 in a patient with gastric cancer.
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Diagnosis, Differential; Drug Combinations; | 2011 |
[Visual disturbance].
Topics: Antimetabolites, Antineoplastic; Antitubercular Agents; Cataract; Central Serous Chorioretinopathy; | 2012 |